Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06870890
NA

Impact of Sarcopenia on Dyspnea in Patients With Asthma

Sponsor: University Hospital, Clermont-Ferrand

View on ClinicalTrials.gov

Summary

Dyspnea in asthma, is mainly due to airway obstruction but can be caused by several alternative diagnoses. The impact of sarcopenia on dyspnea in patients with asthma is unknown. Sarcopenic asthma had a reduced physical activity and is associated with airway obstruction compared to non-sarcopenic asthma. In patients with obstructive pulmonary disease, sarcopenia is associated with shallow breathing and diverse sensory and affective components of exertional dyspnea . The morbidity of sarcopenia is also increased by systemic inflammation and the production of inflammatory cytokines as found in inflammatory airway obstruction. The investigators will investigate the prevalence and impact of sarcopenia in asthmatics patients. This will enable to better manage sarcopenia in asthmatic patients, understand its origins and personalize treatment.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2025-03-25

Completion Date

2026-10

Last Updated

2025-03-11

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

muscle evaluation

The investigators will evaluate the muscle mass and muscle strenght for all patients included

BIOLOGICAL

Dosage

Evaluation of the cinetic of biomarkers during exercise

DIAGNOSTIC_TEST

Cardiopulmonary exercise test

CPET

COMBINATION_PRODUCT

Questionnaire and Physical Exam

Evaluating dyspnea, anxiety, sleep, physical activity, quality of life

Locations (1)

CHU Clermont-Ferrand

Clermont-Ferrand, France